In 2026, Provigil 200mg remains the primary clinical standard for restoring a regular sleep-wake cycle in adults. While smaller doses exist, the 200mg tablet is the specific concentration most often studied for its ability to maintain "executive function" and cognitive clarity without the heavy cardiac load of older-generation stimulants.